PURPOSE: To examine underlying etiologic factors that may explain the racial disparity in non-Hodgkin's lymphoma (NHL) incidence patterns. PATIENTS AND METHODS: We assessed immune-related conditions and risk of developing NHL among more than 4 million hospitalized US veterans including 9,496 patients with NHL (7,999 white patients and 1,497 black patients) with up to 26 years of follow-up. We used time-dependent Poisson regression to estimate rate ratios (RRs) and 95% CIs for NHL risk among patients with a history of specific autoimmune diseases, infections, and allergies compared with patients without such history, adjusting for attained age, calendar year, race, number of hospital visits, and time between study entry and exit. RESULTS: Patients with infectious conditions had an increased risk of developing NHL (RR, 1.2; 95% CI, 1.1 to 1.2), particularly for gastrohepatic, genital, and systemic infectious conditions. Patients with autoimmune disease were generally more likely to develop NHL than patients without autoimmune disease, especially for conditions that typically present with detectable autoantibodies with systemic involvement (RR, 2.0; 95% CI, 1.8 to 2.2). Allergies were also associated with increased risk (RR, 1.4; 95% CI, 1.3 to 1.5). Although the risk of NHL was lower for blacks than whites (RR, 0.87; 95% CI, 0.82 to 0.92), blacks had a slightly higher risk of NHL associated with infections than whites (likelihood ratio test, P = .002) and a tendency toward higher risk associated with allergies (likelihood ratio test, P = .05). Risks associated with autoimmune conditions were similar by race (likelihood ratio test, P = .5). CONCLUSION: The observed difference in NHL risk by race supports a role for race-related differences in genes regulating immune/inflammatory response.
PURPOSE: To examine underlying etiologic factors that may explain the racial disparity in non-Hodgkin's lymphoma (NHL) incidence patterns. PATIENTS AND METHODS: We assessed immune-related conditions and risk of developing NHL among more than 4 million hospitalized US veterans including 9,496 patients with NHL (7,999 white patients and 1,497 black patients) with up to 26 years of follow-up. We used time-dependent Poisson regression to estimate rate ratios (RRs) and 95% CIs for NHL risk among patients with a history of specific autoimmune diseases, infections, and allergies compared with patients without such history, adjusting for attained age, calendar year, race, number of hospital visits, and time between study entry and exit. RESULTS:Patients with infectious conditions had an increased risk of developing NHL (RR, 1.2; 95% CI, 1.1 to 1.2), particularly for gastrohepatic, genital, and systemic infectious conditions. Patients with autoimmune disease were generally more likely to develop NHL than patients without autoimmune disease, especially for conditions that typically present with detectable autoantibodies with systemic involvement (RR, 2.0; 95% CI, 1.8 to 2.2). Allergies were also associated with increased risk (RR, 1.4; 95% CI, 1.3 to 1.5). Although the risk of NHL was lower for blacks than whites (RR, 0.87; 95% CI, 0.82 to 0.92), blacks had a slightly higher risk of NHL associated with infections than whites (likelihood ratio test, P = .002) and a tendency toward higher risk associated with allergies (likelihood ratio test, P = .05). Risks associated with autoimmune conditions were similar by race (likelihood ratio test, P = .5). CONCLUSION: The observed difference in NHL risk by race supports a role for race-related differences in genes regulating immune/inflammatory response.
Authors: Dominik D Alexander; Pamela J Mink; Hans-Olov Adami; Ellen T Chang; Philip Cole; Jack S Mandel; Dimitrios Trichopoulos Journal: Int J Cancer Date: 2007 Impact factor: 7.396
Authors: Mads Melbye; Karin Ekström Smedby; Tuula Lehtinen; Klaus Rostgaard; Bengt Glimelius; Lars Munksgaard; Claudia Schöllkopf; Christer Sundström; Ellen T Chang; Pentti Koskela; Hans-Olov Adami; Henrik Hjalgrim Journal: J Natl Cancer Inst Date: 2007-01-17 Impact factor: 13.506
Authors: Andrew Edwin Grulich; Claire Melissa Vajdic; Sean Riminton; Anne Maree Hughes; Anne Kricker; Bruce Konrad Armstrong Journal: J Natl Cancer Inst Date: 2007-09-11 Impact factor: 13.506
Authors: Pawel Muranski; Andrea Boni; Paul A Antony; Lydie Cassard; Kari R Irvine; Andrew Kaiser; Chrystal M Paulos; Douglas C Palmer; Christopher E Touloukian; Krzysztof Ptak; Luca Gattinoni; Claudia Wrzesinski; Christian S Hinrichs; Keith W Kerstann; Lionel Feigenbaum; Chi-Chao Chan; Nicholas P Restifo Journal: Blood Date: 2008-03-19 Impact factor: 22.113
Authors: Frida Lundmark; Kristina Duvefelt; Ellen Iacobaeus; Ingrid Kockum; Erik Wallström; Mohsen Khademi; Annette Oturai; Lars P Ryder; Janna Saarela; Hanne F Harbo; Elisabeth G Celius; Hugh Salter; Tomas Olsson; Jan Hillert Journal: Nat Genet Date: 2007-07-29 Impact factor: 38.330
Authors: David A Hafler; Alastair Compston; Stephen Sawcer; Eric S Lander; Mark J Daly; Philip L De Jager; Paul I W de Bakker; Stacey B Gabriel; Daniel B Mirel; Adrian J Ivinson; Margaret A Pericak-Vance; Simon G Gregory; John D Rioux; Jacob L McCauley; Jonathan L Haines; Lisa F Barcellos; Bruce Cree; Jorge R Oksenberg; Stephen L Hauser Journal: N Engl J Med Date: 2007-07-29 Impact factor: 91.245
Authors: Lara Stein; Margaret I Urban; Dianne O'Connell; Xue Qin Yu; Valerie Beral; Rob Newton; Paul Ruff; Bernard Donde; Martin Hale; Moosa Patel; Freddy Sitas Journal: Int J Cancer Date: 2008-05-15 Impact factor: 7.396
Authors: Simon G Gregory; Silke Schmidt; Puneet Seth; Jorge R Oksenberg; John Hart; Angela Prokop; Stacy J Caillier; Maria Ban; An Goris; Lisa F Barcellos; Robin Lincoln; Jacob L McCauley; Stephen J Sawcer; D A S Compston; Benedicte Dubois; Stephen L Hauser; Mariano A Garcia-Blanco; Margaret A Pericak-Vance; Jonathan L Haines Journal: Nat Genet Date: 2007-07-29 Impact factor: 38.330
Authors: Rebecca Scherzer; Peter Bacchetti; Geralyn Messerlian; Johanna Goderre; Pauline M Maki; David B Seifer; Kathryn Anastos; Roksana Karim; Ruth M Greenblatt Journal: Am J Reprod Immunol Date: 2014-10-23 Impact factor: 3.886
Authors: Elizabeth K Cahoon; Ruth M Pfeiffer; David C Wheeler; Juan Arhancet; Shih-Wen Lin; Bruce H Alexander; Martha S Linet; D Michal Freedman Journal: Int J Cancer Date: 2014-10-13 Impact factor: 7.396
Authors: Anneclaire J De Roos; Dana K Mirick; Kerstin L Edlefsen; Andrea Z LaCroix; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Otoniel Martínez-Maza Journal: Cancer Res Date: 2012-07-30 Impact factor: 12.701
Authors: Amy M Linabery; Anna E Prizment; Kristin E Anderson; James R Cerhan; Jenny N Poynter; Julie A Ross Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-24 Impact factor: 4.254